These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11055336)

  • 1. NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain.
    LaPlante SR; Aubry N; Bonneau PR; Kukolj G; Lamarre D; Lefebvre S; Li H; Llinàs-Brunet M; Plouffe C; Cameron DR
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2271-4. PubMed ID: 11055336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies.
    Cicero DO; Barbato G; Koch U; Ingallinella P; Bianchi E; Nardi MC; Steinkühler C; Cortese R; Matassa V; De Francesco R; Pessi A; Bazzo R
    J Mol Biol; 1999 Jun; 289(2):385-96. PubMed ID: 10366512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors.
    Llinàs-Brunet M; Bailey M; Fazal G; Ghiro E; Gorys V; Goulet S; Halmos T; Maurice R; Poirier M; Poupart MA; Rancourt J; Thibeault D; Wernic D; Lamarre D
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2267-70. PubMed ID: 11055335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.
    Barbato G; Cicero DO; Cordier F; Narjes F; Gerlach B; Sambucini S; Grzesiek S; Matassa VG; De Francesco R; Bazzo R
    EMBO J; 2000 Mar; 19(6):1195-206. PubMed ID: 10716920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexapeptide functionality of cellulose as NS3 protease inhibitors.
    Ibrahim M; Saleh NA; Elshemey WM; Elsayed AA
    Med Chem; 2012 Sep; 8(5):826-30. PubMed ID: 22741792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus NS3/4A protease.
    Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
    Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-based inhibitors of the hepatitis C virus serine protease.
    Llinàs-Brunet M; Bailey M; Fazal G; Goulet S; Halmos T; Laplante S; Maurice R; Poirier M; Poupart MA; Thibeault D; Wernic D; Lamarre D
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1713-8. PubMed ID: 9873421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transfer.
    Fattori D; Urbani A; Brunetti M; Ingenito R; Pessi A; Prendergast K; Narjes F; Matassa VG; De Francesco R; Steinkühler C
    J Biol Chem; 2000 May; 275(20):15106-13. PubMed ID: 10809747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease.
    Llinàs-Brunet M; Bailey M; Déziel R; Fazal G; Gorys V; Goulet S; Halmos T; Maurice R; Poirier M; Poupart MA; Rancourt J; Thibeault D; Wernic D; Lamarre D
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2719-24. PubMed ID: 9873610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of SCH446211 (SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication.
    Bogen SL; Arasappan A; Bennett F; Chen K; Jao E; Liu YT; Lovey RG; Venkatraman S; Pan W; Parekh T; Pike RE; Ruan S; Liu R; Baroudy B; Agrawal S; Chase R; Ingravallo P; Pichardo J; Prongay A; Brisson JM; Hsieh TY; Cheng KC; Kemp SJ; Levy OE; Lim-Wilby M; Tamura SY; Saksena AK; Girijavallabhan V; Njoroge FG
    J Med Chem; 2006 May; 49(9):2750-7. PubMed ID: 16640336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 2-oxoimidazolidine-4-carboxylic acid derivatives as hepatitis C virus NS3-4A serine protease inhibitors: synthesis, activity, and X-ray crystal structure of an enzyme inhibitor complex.
    Arasappan A; Njoroge FG; Parekh TN; Yang X; Pichardo J; Butkiewicz N; Prongay A; Yao N; Girijavallabhan V
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5751-5. PubMed ID: 15501035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel azapeptide inhibitors of hepatitis C virus serine protease.
    Bailey MD; Halmos T; Goudreau N; Lescop E; Llinàs-Brunet M
    J Med Chem; 2004 Jul; 47(15):3788-99. PubMed ID: 15239657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
    Tsantrizos YS
    Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
    Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
    J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational changes in human hepatitis C virus NS3 protease upon binding of product-based inhibitors.
    Bianchi E; Orrù S; Dal Piaz F; Ingenito R; Casbarra A; Biasiol G; Koch U; Pucci P; Pessi A
    Biochemistry; 1999 Oct; 38(42):13844-52. PubMed ID: 10529230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimization.
    Perni RB; Pitlik J; Britt SD; Court JJ; Courtney LF; Deininger DD; Farmer LJ; Gates CA; Harbeson SL; Levin RB; Lin C; Lin K; Moon YC; Luong YP; O'Malley ET; Rao BG; Thomson JA; Tung RD; Van Drie JH; Wei Y
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1441-6. PubMed ID: 15006379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease.
    Malancona S; Colarusso S; Ontoria JM; Marchetti A; Poma M; Stansfield I; Laufer R; Di Marco A; Taliani M; Verdirame M; Gonzalez-Paz O; Matassa VG; Narjes F
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4575-9. PubMed ID: 15357995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus.
    Ingallinella P; Fattori D; Altamura S; Steinkühler C; Koch U; Cicero D; Bazzo R; Cortese R; Bianchi E; Pessi A
    Biochemistry; 2002 Apr; 41(17):5483-92. PubMed ID: 11969409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
    Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.